|
|
Article: Former Biogen executive vice president Sylvie Gregoire named CEO of GlycoFi.
- Article from:
- Health & Medicine Week
- Article date:
- November 1, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 NOV 1 - (NewsRx.com & NewsRx.net) -- GlycoFi, Inc. announced the appointment of Sylvie Gregoire, PharmD, as chief executive officer.
She joins the company from Biogen (now Biogen Idec) where she was executive vice president, Technical Operations. Gregoire replaces Charles E. Hutchinson, PhD, who remains with GlycoFi in the role of executive chairman of the board of directors.
Gregoire has 17 years of international and U.S. experience within the biotechnology and pharmaceutical industries. Her career has included positions in manufacturing, regulatory affairs, program management, clinical research and clinical pharmacology. She initially joined ...
Related newspaper, magazine, and journal articles:
|
|
Article: Shire Appoints Sylvie Gregoire President of Human ...
PR Newswire;
September 24, 2007 ;
700+ words
... ... specialty biopharmaceutical company, announced today that Sylvie Gregoire has been appointed President of its Human Genetic Therapies ... therapies for patients suffering from genetic diseases," said Sylvie Gregoire, President of Shire HGT. "Elaprase has been successfully ...
|
|